Results of cervical cancer trial hailed as 'biggest breakthrough for decades'

14 October 2024

Findings from a CTC-led study into cervical cancer treatment have been published in the Lancet today, prompting further coverage for a trial which first caught the attention of the public last year.

Results for the INTERLACE trial have shown a course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer.

The results were first presented to the public at the ESMO conference last October. More information can be read in our article at the time.

The CTC media team interviewed the trial's CI, one of its patients, and one of the statisticians responsible for deciphering the results. The article was published as part of UCL's digital campaign for World Cancer Day this year.

External links

The Lancet | INTERLACE paper

The Guardian | New cervical cancer treatment regime 'cuts risk of dying from disease by 40%'

The Times | New treatment regimen cuts cervical cancer deaths by 40%

Sky News | Simple tweak to cervical cancer treatment cuts risk of death by 40%, say researchers

The Independent | Treatment cuts cervical cancer deaths by 40% in 'biggest breakthrough for decades'

Cancer Research UK | Cervical cancer treatment breakthrough cuts risk of death by 40%

More news articles

Cervical Cancer Prevention Week in the UK

This week (20 January - 26 January) marks Cervical Cancer Prevention Week in the United Kingdom. Launched by Jo's Cervical Cancer Trust, the [...]

Report on underrepresentation of Black and minority ethnic communities in clinical trials published

In 2022, the Cancer Research UK & UCL Cancer Trials Centre (CTC) and B’Me Against Cancer (now The Rose Thompson Foundation) commissioned Dr [...]

'Bridging the Gap': CTC organises collaborative event to raise awareness of clinical trials

Esther Arthur-Darkwa, trial manager at the Cancer Trials Centre, reports back from this weekend's event in Nottingham: In 2022 the UCL CTC e [...]

Results of cervical cancer trial hailed as 'biggest breakthrough for decades'

Findings from a CTC-led study into cervical cancer treatment have been published in the Lancet today, prompting further coverage for a trial [...]

Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map

Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899

CTC staff

University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000